Physician profile
Desry A Hyacinth
NPI 1134849904
$1,111.37
in general payments reported to CMS, 2019-2025
20 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $164 · 2024: $547 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $380.07 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $134.98 | 2024-2025 | Onpattro, Amvuttra |
| Novartis Pharmaceuticals Corporation | $65.74 | 2024-2025 | |
| Cvrx, INC. | $57.21 | 2024-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $55.36 | 2023-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $55.28 | 2024-2025 | Camzyos, Eliquis |
| United Therapeutics Corporation | $54.49 | 2023-2024 | Tyvaso |
| Kiniksa Pharmaceuticals International, Plc | $49.21 | 2024 | Arcalyst |
| Atricure, INC. | $48.97 | 2024-2025 | Synergy Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $27.67 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $22.52 | 2025 | Uptravi |
| Scpharmaceuticals INC. | $22.49 | 2024 | |
| Corcept Therapeutics | $19.91 | 2025 | Korlym |
| Lexicon Pharmaceuticals, INC. | $19.89 | 2023 | Inpefa |
| Biosense Webster, INC. | $17.80 | 2025 | Carto 3 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.57 | 2023 | Xarelto |
| Inspire Medical Systems, INC. | $17.40 | 2025 | Inspire |
| Daiichi Sankyo INC. | $16.78 | 2025 | Injectafer |
| Novo Nordisk INC | $14.99 | 2024 | Ozempic |
| Medtronic, INC. | $13.04 | 2023 | Mycarelink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desry Hyacinth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.